Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model.
Nanxin LiEileen K SawyerKonrad MaruszczykGregory F GuzauskasMarta T SlomkaTom BurkeAntony Paul MartinJamie O'HaraMatthew D StevensonMichael RechtPublished in: Journal of medical economics (2021)
This decision analytic model demonstrated significant economic burden associated with the current HB treatment paradigm.
Keyphrases